EUVIMEDEUVIMED entdecken
Open Access

Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia

Po-Huang Chen, Hong-Jie Jhou, Cho-Hao Lee

Cochrane Database of Systematic Reviews · 2025

DOI: 10.1002/14651858.cd016090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Database of Systematic Reviews, 2025. Verfasst von Po-Huang Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Maintenance Chemotherapy. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of FLT3 TKIs as maintenance therapy compared to no maintenance therapy or alternative strategies for participants with FLT3-mutated AML after allo-HSCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

fms-Like Tyrosine Kinase 3Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteMaintenance ChemotherapyProtein Kinase InhibitorsHumansDasatinibMutationPhenylurea CompoundsRandomized Controlled Trials as TopicTyrosine Kinase InhibitorsSystematic Reviews as Topic

Substanzen

DasatinibFLT3 protein, humanfms-Like Tyrosine Kinase 3Phenylurea CompoundsProtein Kinase InhibitorsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan.

Zitieren

APA

Chen, P. H., Jhou, H. J., & Lee, C. H. (2025). Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd016090

Vancouver

Chen PH, Jhou HJ, Lee CH. Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia. Cochrane Database of Systematic Reviews. 2025. doi:10.1002/14651858.cd016090

BibTeX
@article{Chen2025,
  author = {Chen, Po-Huang and Jhou, Hong-Jie and Lee, Cho-Hao},
  title = {Tyrosine kinase inhibitor maintenance therapy after stem cell transplantation for FLT3-mutated acute myeloid leukemia},
  journal = {Cochrane Database of Systematic Reviews},
  year = {2025},
  doi = {10.1002/14651858.cd016090}
}
Kostenlos starten →